Regulation of blood pressure and renal function by NCC and ENaC: lessons from genetically engineered mice
- 1 April 2015
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 21, 60-72
Abstract
No abstract availableKeywords
Funding Information
- National Center of Competence in Research
- Swiss National Science Foundation
- Leducq Foundation
This publication has 116 references indexed in Scilit:
- Mutations of the Serine Protease CAP1/Prss8 Lead to Reduced Embryonic Viability, Skin Defects, and Decreased ENaC ActivityThe American Journal of Pathology, 2012
- Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalitiesNature, 2012
- Impaired phosphorylation of Na + -K + -2Cl − cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndromeProceedings of the National Academy of Sciences, 2011
- The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertensionNature Medicine, 2011
- Exploring the intricate regulatory network controlling the thiazide-sensitive NaCl cotransporter (NCC)Pflügers Archiv - European Journal of Physiology, 2011
- A SPAK Isoform Switch Modulates Renal Salt Transport and Blood PressureCell Metabolism, 2011
- Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertensionProceedings of the National Academy of Sciences, 2010
- Role of the WNK‐activated SPAK kinase in regulating blood pressureEMBO Molecular Medicine, 2010
- ENaC‐mediated alveolar fluid clearance and lung fluid balance depend on the channel‐activating protease 1EMBO Molecular Medicine, 2009
- Renal expression of parvalbumin is critical for NaCl handling and response to diureticsProceedings of the National Academy of Sciences, 2007